Vitamin D Status is Not Associated with Risk for Less Common Cancers

June 18, 2010

( -- Despite hopes that higher blood levels of vitamin D might reduce cancer risk, a large study finds no protective effect against non-Hodgkin lymphoma or cancer of the endometrium, esophagus, stomach, kidney, ovary, or pancreas.

In this study, carried out by researchers from the National Institute (NCI), part of the National Institutes of Health, and many other research institutions, data based on blood samples originally drawn for 10 individual studies were combined to investigate whether people with high levels of were less likely to develop these rarer cancers. Details of these analyses appear as a set of papers in the June 18, 2010, online issue of the , and in print in the July 2010 issue.

"We did not see lower cancer risk in persons with high vitamin D blood concentrations compared to normal concentrations for any of these cancers," said Demetrius Albanes, M.D., NCI, one of the study investigators. "And, at the other end of the vitamin D spectrum, we did not see higher cancer risk for participants with low levels."

As part of a collaborative effort of the NCI Cohort Consortium, investigators from the Vitamin D Pooling Project of Rarer Cancers examined vitamin D levels in blood that had been collected from over 12,000 men and women participating in one of the studies. Some of those individuals went on to develop cancer. Vitamin D concentrations were measured using 25-hydroxyvitamin D (25(OH)D), which is the major form of this vitamin in the bloodstream.

Participants were followed for the development of cancer for up to 33 years, depending on the study. Investigators then compared cancer rates in participants whose levels of vitamin D in stored blood were high (above 75 nmol/L, or nanomoles per liter) or low (less than 25 nmol/L) with rates in participants whose levels of vitamin D were within the normal range (50 to 75 nmol/L).

For the small number of participants with vitamin D levels greater than 100 nmol/L, investigators observed elevated risk of pancreatic cancer, but not for the other cancers in these studies. They recommended further research to clarify this relationship.

Vitamin D is made naturally by the body when the skin is exposed to sunlight; it can also be obtained from a few foods in which it occurs naturally, from fortified foods, and from nutritional supplements. Vitamin D is essential for healthy bones, calcium absorption, and immune function.

Researchers and clinicians have looked to the possibility that vitamin D might be used for cancer prevention. Some evidence indicates that higher levels of vitamin D are associated with a lower risk of colorectal cancer, though the evidence is inconsistent.

Through the Vitamin D Pooling Project, researchers had access to a geographically and demographically diverse group of men and women, including participants from the United States, Finland, and China.

In this collection of groups of study participants, the proportion of the study population that was deficient in vitamin D varied from 3 percent to 36 percent, depending on geographical latitude, season during which the blood was collected, race, and other factors. The investigators had a wealth of other information on participants, including smoking history, lifestyle, and diet. As in other studies, individuals with higher 25(OH)D levels were more likely to be male, lean, and physically active. Those with higher levels also reported greater intake of multivitamins, calcium supplements, and foods rich in vitamin D.

"In this pooled analysis of cohort data, vitamin D was not associated with lower risk for these less common cancers, despite well-established benefits for bone health," concluded Albanes.

Many people in the United States and around the world have low concentrations of 25(OH)D. The current recommended daily intake of vitamin D to maintain bone health and normal calcium metabolism, according to the Food and Nutrition Board of the Institute of Medicine, National Academy of Sciences, ranges from 200 IU (international units) to 600 IU, depending on age, with the highest dose recommendations being for the elderly. In addition, the 2005 Dietary Guidelines for Americans recommends that older adults, people with dark skin, and those exposed to insufficient sunlight consume extra vitamin D from vitamin D-fortified foods and/or supplements. Since there are very few foods which naturally contain vitamin D (fatty fish, fish liver oil, and eggs), most dietary vitamin D comes from fortified foods such as milk, juice, yogurt, bread and breakfast cereals.

More information: References:

Nine papers, all appearing in the American Journal of Epidemiology, online June 18, 2010, and in print in the July 2010 issue:

-- Overview of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Kathy J. Helzlsouer for the VDPP Steering Committee.
-- Circulating 25-hydroxyvitamin D and Risk of Esophageal and Gastric Cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Abnet C.C., Chen Yu, et. al.
-- Circulating 25-hydroxyvitamin D and Risk of Pancreatic Cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Stolzenberg-Solomon R, Jacobs EJ,
-- Circulating 25-hydroxyvitamin D and Risk of Kidney Cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Gallicchio L, Moore LE, et. al.
-- Circulating 25-hydroxyvitamin D and the Risk of Rarer Cancers: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers Design and Methods. Gallicchio L, Helzlsouer KJ, et. al.
-- Circulating 25-hydroxyvitamin D and Risk of Endometrial Cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Zeleniuch-Jacquotte A, Gallicchio L, et. al.
-- Circulating 25-hydroxyvitamin D and Risk of Epithelial Ovarian Cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Zheng W, Danforth KN, et. al.
-- Circulating 25-hydroxyvitamin D and Risk of non-Hodgkin Lymphoma: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Purdue MP, Michal Freedman D, et. al.
-- Correlates of circulating 25-hydroxyvitamin D: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. McCullough ML, Weinstein SJ, et. al.

Related Stories

Recommended for you

Alternative splicing, an important mechanism for cancer

September 22, 2017
Cancer, which is one of the leading causes of death worldwide, arises from the disruption of essential mechanisms of the normal cell life cycle, such as replication control, DNA repair and cell death. Thanks to the advances ...

'Labyrinth' chip could help monitor aggressive cancer stem cells

September 21, 2017
Inspired by the Labyrinth of Greek mythology, a new chip etched with fluid channels sends blood samples through a hydrodynamic maze to separate out rare circulating cancer cells into a relatively clean stream for analysis. ...

Drug combination may improve impact of immunotherapy in head and neck cancer

September 21, 2017
Checkpoint inhibitor-based immunotherapy has been shown to be very effective in recurrent and metastatic head and neck cancer but only in a minority of patients. University of California San Diego School of Medicine researchers ...

Whole food diet may help prevent colon cancer, other chronic conditions

September 21, 2017
A diet that includes plenty of colorful vegetables and fruits may contain compounds that can stop colon cancer and inflammatory bowel diseases in pigs, according to an international team of researchers. Understanding how ...

New kinase detection method helps identify targets for developing cancer drugs

September 21, 2017
Purdue University researchers have developed a high-throughput method for matching kinases to the proteins they phosphorylate, speeding the ability to identify multiple potential cancer drug targets.

Brain cancer growth halted by absence of protein, study finds

September 20, 2017
The growth of certain aggressive brain tumors can be halted by cutting off their access to a signaling molecule produced by the brain's nerve cells, according to a new study by researchers at the Stanford University School ...


Adjust slider to filter visible comments by rank

Display comments: newest first

not rated yet Jun 18, 2010
Amazing, all those authors and not one of them knows that "vitamin" D is a secosteroid!
No vitamin content whatsoever.
As a steroid it deactivates the VDR gene which controls the immune system.
That's why increasing D doesn't improve you'r chances with cancer, like all steroids it's immunosupressant and it doesn't improve bone health either, it just reduces the pain associated with arthritis to increase mobility.
You lot need to throw your old books away and get on the internet for some up to date information.
Try starting here- http://autoimmuni...VitD.pdf
not rated yet Jun 20, 2010
You undermine your credibility by pulling a single article off the web and proclaiming the mainstream view to be wrong.

Vitamin D is a vitamin. That is not inconsistent with it being a fat-soluble secosteroids. In the absence of sufficient sunlight, the body must get this fat-soluble secosteroid from food. Hence it is a vitamin ...

The evidence suggests the vitamin D modules immune activity, not that it suppresses it.

Lots of people take high doses of vitamin D without suffering frequent illness.

Lots of evidence suggests that insufficent vitamin D is associated with cancer and that vitamin D reduces the likelihood of cancer by stimulating the immune system.
not rated yet Jun 22, 2010
Lot's of OLD evidence.
I could fill the entire page with new evidence but why not check for yourself.
Ask yourself, why do people take high doses of D if it is a vitamin?
Vitamins are not painkillers and the body will send an over abundance of vitamins down the toilet before the body goes into distress!

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.